Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Huntington Disease

n(g),n(g')-dimethyl-l-arginine has been researched along with Huntington Disease in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skene, DJ1
Middleton, B1
Fraser, CK1
Pennings, JL1
Kuchel, TR1
Rudiger, SR1
Bawden, CS1
Morton, AJ1

Other Studies

1 other study available for n(g),n(g')-dimethyl-l-arginine and Huntington Disease

ArticleYear
Metabolic profiling of presymptomatic Huntington's disease sheep reveals novel biomarkers.
    Scientific reports, 2017, 02-22, Volume: 7

    Topics: Amino Acids, Branched-Chain; Animals; Animals, Genetically Modified; Area Under Curve; Arginine; Bio

2017